Circadian provides management and funding for the development and commercialisation of Australian biomedical research. It has major holdings in Optiscan, Metabolic Pharmaceuticals, and Antisence amongst others. It also maintains an active research and development program.
For those interested...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.